2000-2022年药品支出动态（英）

OCTOBER2 0 2 5Understanding Medicine and Healthcare Spending in ContextDrug Expenditure Dynamics 2000–2022The level of drug expenditure is a closely watched, often commented upon, metric that has faced increased scrutiny by policymakers and other stakeholders in recent times. Issues such as global trade balances, medicine pricing, and international investment decisions are top priorities for countries and pharmaceutical companies alike, leading to a renewed interest in the level of spending on drugs globally. Despite this, the composition of that expenditure and its dynamics are not well understood. Typically, official statistics of drug spending only include drugs dispensed in pharmacies and do not include drugs used in hospitals, an issue which raises questions about their representativeness of total drug spending. In October 2021, the IQVIA Institute published a report titled ‘Drug Expenditure Dynamics 1995–2020’ with estimates of total drug spending, including hospitals and net of discounts and rebates paid by pharmaceutical companies.i Almost four years on from the original publication, an update of the core analyses has been conducted to provide an improved picture beyond publicly reported data. The latest findings build upon previous analyses, enhance and revise the methodologies, and further illustrate the complexities of comparing systems. The report focuses on a subset of specific countries to enable greater granularity and have included a robust appendix of analyses for each country.The research for this report was undertaken independently by the IQVIA Institute with the support of the Association of the British Pharmaceutical Industry (ABPI). The contributions to this report of Tanya Bhardwaj, Urvashi Porwal, Vibhu Tewary and dozens of others at IQVIA are gratefully acknowledged. Find Out MoreIf you wish to receive future reports from the IQVIA Institute for Human Data Science or join our mailing list, visit iqviainstitute.org. MURRAY AITKENExecutive Director IQVIA Institute for Human Data ScienceIntroduction©2025 IQVIA and its affiliates. All reproduction rights, quotations, broadcasting, publications reserved. No part of this publication may be reproduced or transmitted in any form or by any means, electronic or mechanical, including photocopy, recording, or any information storage and retrieval system, without express written consent of IQVIA and the IQVIA Institute.Drug Expenditure Dynamics 2000–2022: Understanding Medicine and Healthcare Spending in ContextREFERENCING THIS REPORTPlease use this format when referencing content from this report:Source: IQVIA Institute for Human Data Science. Report: Drug Expenditure Dynamics 2000–2022: Understanding Medicine and Healthcare Spending in Context. October 2025. Available from www.iqviainstitute.orgTable of ContentsOverview 2Understanding components of drug expenditure 3 Total drug expenditure is the most meaningful metric 3 Public sources have incomplete data on total drug expenditure